Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study Testing Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in the Context of Organ Preservation for Patients With Rectal Cancer

NCT03051464 is registered in ClinicalTrials.gov with Sir Mortimer B. Davis - Jewish General Hospital as lead sponsor.

NCT NCT03051464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03051464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study Testing Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in the Context of Organ Preservation for Patients With Rectal Cancer
Lead sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 25, 2017
Completion date
January 31, 2030
Enrollment
131 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

non-operative treatment, organ preservation, rectal cancer (stage iii), rectal cancer patients, stage ii rectal cancer